Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Drug Resistance

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 102 articles:
HTML format
Text format



Single Articles


    August 2018
  1. NELSON RE, Evans ME, Simbartl L, Jones M, et al
    Methicillin-resistant Staphylococcus aureus Colonization and Pre- and Post-hospital Discharge Infection Risk.
    Clin Infect Dis. 2018 Aug 11. pii: 5069896. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  2. THOMPSON JA, Kityo C, Dunn D, Hoppe A, et al
    Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomised trial.
    Clin Infect Dis. 2018 Jul 28. pii: 5060946. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. BEN-DAVID D, Masarwa S, Fallach N, Temkin E, et al
    Success of a National Intervention in Controlling Carbapenem-Resistant Enterobacteriaceae in Israel's Long-Term Care Facilities.
    Clin Infect Dis. 2018 Jul 9. pii: 5050699. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. CHEN XS, Yin YP, Li XY
    A ROADMAP plan to address research needs for gonococcal antimicrobial resistance in China.
    Clin Infect Dis. 2018 Jul 9. pii: 5050687. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  5. RANDOLPH AG, Xu R, Novak T, Newhams MM, et al
    Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant Staphylococcus aureus Coinfection in Children with Influenza-Related Critical Illness.
    Clin Infect Dis. 2018 Jun 9. pii: 5035208. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  6. KLEIN EY, Jiang W, Mojica N, Tseng KK, et al
    National Costs Associated with Methicillin-susceptible and Methicillin-resistant S. aureus Hospitalizations in the United States, 2010-2014.
    Clin Infect Dis. 2018 May 12. pii: 4995458. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. CASSONE M, Mantey J, Perri MB, Gibson K, et al
    Environmental Panels as a Proxy for Nursing Facility Patients With Methicillin-Resistant Staphylococcus Aure and Vancomycin-Resistant Enterococcus Colonization.
    Clin Infect Dis. 2018 May 2. pii: 4991833. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  8. ZAK-DORON Y, Dishon Benattar Y, Pfeffer I, Daikos GL, et al
    The Association between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria: A Prospective Study.
    Clin Infect Dis. 2018 Apr 27. pii: 4987600. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. SATLIN MJ, Chavda KD, Baker TM, Chen L, et al
    Colonization with Levofloxacin-Resistant Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
    Clin Infect Dis. 2018 Apr 26. pii: 4986473. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. GUALANDI N, Mu Y, Bamberg WM, Dumyati G, et al
    Racial Disparities in Invasive Methicillin-Resistant Staphylococcus aureus Infections, 2005-2014.
    Clin Infect Dis. 2018 Apr 5. pii: 4961420. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  11. BOJANG A, Camara B, Jagne Cox I, Oluwalana C, et al
    Long-term Impact of Oral Azithromycin taken by Gambian women during Labour on Prevalence and Antibiotic Susceptibility of S. pneumoniae and S. aureus in their Infants: Follow up of a Randomized Clinical Trial.
    Clin Infect Dis. 2018 Mar 28. pii: 4955815. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  12. RAY MJ, Lin MY, Tang AS, Arwady MA, et al
    Regional Spread of an Outbreak of Carbapenem-Resistant Enterobacteriaceae (CRE) through an Ego Network of Healthcare Facilities.
    Clin Infect Dis. 2018 Feb 3. pii: 4836930. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  13. NIGO M, Luce AM, Arias CA
    Long Term Use of Tedizolid as Suppressive Therapy for Recurrent Methicillin-Resistant Staphylococcus aureus Graft Infection.
    Clin Infect Dis. 2018 Jan 23. pii: 4819116. doi: 10.1093.
    PubMed     Text format    


  14. KENYON C
    Risks of antimicrobial resistance in N. gonorrhoeae associated with intensive screening programs in PrEP programs.
    Clin Infect Dis. 2018 Jan 23. pii: 4821305. doi: 10.1093.
    PubMed     Text format    


  15. JENNESS SM, Weiss KM, Goodreau SM, Gift T, et al
    Moving Forward with Treatment of Gonorrhea for Users of HIV Preexposure Prophylaxis Given the Threat of Antimicrobial Resistance.
    Clin Infect Dis. 2018 Jan 23. pii: 4821306. doi: 10.1093.
    PubMed     Text format    


  16. NADIMPALLI M, Delarocque-Astagneau E, Love DC, Price LB, et al
    Combating Global Antibiotic Resistance: Emerging One Health Concerns in Lower- and Middle-Income Countries.
    Clin Infect Dis. 2018 Jan 15. pii: 4810441. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. PARENTE DM, Cunha CB, Mylonakis E, Timbrook TT, et al
    The Clinical Utility of Methicillin Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis with Antimicrobial Stewardship Implications.
    Clin Infect Dis. 2018 Jan 11. pii: 4798927. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. GORRIE CL, Mirceta M, Wick RR, Judd LM, et al
    Antimicrobial resistant Klebsiella pneumoniae carriage and infection in specialized geriatric care wards linked to acquisition in the referring hospital.
    Clin Infect Dis. 2018 Jan 11. pii: 4798841. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  19. LIN MY, Hayden MK, Lyles RD, Lolans K, et al
    Regional Epidemiology of Methicillin-Resistant Staphylococcus aureus among Adult Intensive Care Unit Patients following State-Mandated Active Surveillance.
    Clin Infect Dis. 2017 Dec 7. pii: 4706267. doi: 10.1093/cid/cix1056.
    PubMed     Text format     Abstract available


  20. WOUDT SHS, de Greeff SC, Schoffelen AF, Vlek ALM, et al
    Antibiotic resistance and the risk of recurrent bacteremia.
    Clin Infect Dis. 2017 Dec 7. pii: 4706269. doi: 10.1093/cid/cix1076.
    PubMed     Text format     Abstract available


    November 2017
  21. HUMPHRIES RM, Hindler JA, Epson E, Horwich-Scholefield S, et al
    Carbapenem-resistant Enterobacteriaceae (CRE) detection practices in California: What are we missing?
    Clin Infect Dis. 2017 Nov 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  22. HAWKEN SE, Washer LL, Williams CL, Newton DW, et al
    Genomic Investigation of a Putative Endoscope-Associated Carbapenem-Resistant Enterobacter cloacae Outbreak Reveals a Wide Diversity of Circulating Strains and Resistance Mutations.
    Clin Infect Dis. 2017 Oct 26. pii: 4565785. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. TOLEMAN MS, Watkins ER, Williams T, Blane B, et al
    Investigation of a Cluster of Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Transmission in a Community Setting.
    Clin Infect Dis. 2017 Oct 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. FARHAT MR, Jacobson KR, Franke MF, Kaur D, et al
    Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study.
    Clin Infect Dis. 2017;65:1364-1370.
    PubMed     Text format     Abstract available


  25. ARDAL C, Rottingen JA, Opalska A, Van Hengel AJ, et al
    Pull Incentives for Antibacterial Drug Development: An Analysis by the Transatlantic Task Force on Antimicrobial Resistance.
    Clin Infect Dis. 2017;65:1378-1382.
    PubMed     Text format     Abstract available


    September 2017
  26. SCHROEDER MR, Chancey ST, Thomas S, Kuo WH, et al
    A Population-Based Assessment of the Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines on Macrolide-Resistant Invasive Pneumococcal Disease: Emergence and Decline of Streptococcus pneumoniae Serotype 19A (CC320) With Dual Macrolide Resistance
    Clin Infect Dis. 2017;65:990-998.
    PubMed     Text format     Abstract available


  27. GURIEVA T, Dautzenberg MJD, Gniadkowski M, Derde LPG, et al
    The transmissibility of antibiotic-resistant Enterobacteriaceae in Intensive Care Units.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. LEUNG V, Vincent C, Edens T, Miller M, et al
    Antimicrobial resistance gene acquisition and depletion following fecal microbiota transplantation (FMT) for recurrent Clostridium difficile infection.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. MILES-JAY A, Weissman SJ, Adler AL, Tchesnokova V, et al
    Epidemiology and antimicrobial resistance characteristics of the ST131-H30 subclone among extraintestinal Escherichia coli collected from US children.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. KATZ AR, Komeya AY, Kirkcaldy RD, Whelen AC, et al
    Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.
    Clin Infect Dis. 2017;65:918-923.
    PubMed     Text format     Abstract available


  31. KOSSOW A, Kampmeier S, Willems S, Berdel WE, et al
    Control of Multidrug-Resistant Pseudomonas aeruginosa in Allogeneic Hematopoietic Stem Cell Transplant Recipients by a Novel Bundle Including Remodeling of Sanitary and Water Supply Systems.
    Clin Infect Dis. 2017;65:935-942.
    PubMed     Text format     Abstract available


  32. WOLF J, Tang L, Flynn PM, Pui CH, et al
    Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.
    Clin Infect Dis. 2017 Sep 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. VAN DUIN D, Lok JJ, Earley M, Cober E, et al
    Colistin vs. Ceftazidime-avibactam in the Treatment of Infections due to Carbapenem-Resistant Enterobacteriaceae.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2017
  34. KNIGHT GM, Costelloe C, Murray KA, Robotham JV, et al
    Addressing the unknowns of antimicrobial resistance: quantifying and mapping the drivers of burden.
    Clin Infect Dis. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. TASHIRO M, Fushimi K, Kawano K, Takazono T, et al
    Comparison of efficacy of antimicrobial agents among hospitalized patients with Mycoplasma pneumoniae pneumonia in Japan during large epidemics of macrolide-resistant M. pneumoniae infections: A nationwide observational study.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. ABAT C, Rolain JM, Dubourg G, Fournier PE, et al
    Evaluating the Clinical Burden and Mortality Attributable to Antibiotic Resistance: The Disparity of Empirical Data and Simple Model Estimations.
    Clin Infect Dis. 2017;65.
    PubMed     Text format     Abstract available


  37. MACESIC N, Nelson B, Uhlemann AC
    Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: De Novo or Drug Exposure?
    Clin Infect Dis. 2017;65:702-703.
    PubMed     Text format    


  38. JORDAN MR, Penazzato M, Cournil A, Vubil A, et al
    HIV drug resistance in African infants and young children newly diagnosed with HIV: a multicounty analysis.
    Clin Infect Dis. 2017 Aug 8. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. SCHECHTER MC, Bizune D, Kagei M, Machaidze M, et al
    Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-Resistant Tuberculosis in Atlanta, Georgia.
    Clin Infect Dis. 2017 Aug 3. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2017
  40. KLEINE CE, Schlabe S, Hischebeth GTR, Molitor E, et al
    Successful therapy of a multi-resistant EBSL (SHV-12)-producing and fluoroquinolone-resistant Salmonella enterica subsp. enterica serovar Typhi infection using combination therapy of meropenem and fosfomycin.
    Clin Infect Dis. 2017 Jul 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  41. KLEIN EY, Mojica N, Jiang W, Cosgrove SE, et al
    Trends in Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010-2014.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. AVERBUCH D, Tridello G, Hoek J, Mikulska M, et al
    Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant patients: intercontinental prospective study of Infectious Diseases Working Party of the European Bone Marrow Transplantation group.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  43. GEISSLER AL, Bustos Carrillo F, Swanson K, Patrick ME, et al
    Increasing Campylobacter Infections, Outbreaks, and Antimicrobial Resistance in the United States, 2004-2012.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. SCHWABER MJ, Carmeli Y
    The Impact of a Carbapenem-Resistant Enterobacteriaceae Outbreak on Facilitating Development of a National Infrastructure for Infection Control in Israel.
    Clin Infect Dis. 2017 Jul 19. doi: 10.1093.
    PubMed     Text format     Abstract available


  45. FABRE V, Cosgrove SE
    A Coordinated and Sustained Response to the Threat of Antibiotic Resistance Is Critical: Lessons Learned From Israel.
    Clin Infect Dis. 2017 Jul 18. doi: 10.1093.
    PubMed     Text format    


    June 2017
  46. JIMENEZ A, Abbo L, Gebrezgi MT
    Importance of carbapenemase production detection in Carbapenem Resistant Enterobacteriaceae. Looking beyond epidemiological purposes.
    Clin Infect Dis. 2017 Jun 16. doi: 10.1093.
    PubMed     Text format    


  47. KOULLIAS Y, Sax PE, Fields NF, Walensky RP, et al
    Should we be testing for baseline integrase resistance in patients newly diagnosed with HIV?
    Clin Infect Dis. 2017 Jun 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. LAMOTH F, Chung SJ, Damonti L, Alexander BD, et al
    Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.
    Clin Infect Dis. 2017;64:1619-1621.
    PubMed     Text format     Abstract available


    May 2017
  49. LARSEN J, Petersen A, Larsen AR, Sieber RN, et al
    Emergence of livestock-associated methicillin-resistant Staphylococcus aureus bloodstream infections in Denmark.
    Clin Infect Dis. 2017 May 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  50. HOOK EW 3RD
    Continued Evolution of Gonococcal Antimicrobial Resistance.
    Clin Infect Dis. 2017 May 26. doi: 10.1093.
    PubMed     Text format    


  51. FELD JJ, Ramji A, Shafran SD, Willems B, et al
    Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study.
    Clin Infect Dis. 2017 May 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  52. CHO SY, Chung DR
    Infection Prevention Strategy in Hospitals in the Era of Community-Associated Methicillin-Resistant Staphylococcus aureus in the Asia-Pacific Region: A Review.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  53. APISARNTHANARAK A, Ratz D, Khawcharoenporn T, Patel PK, et al
    National Survey of Practices to Prevent Methicillin-Resistant Staphylococcus aureus and Multidrug-Resistant Acinetobacter baumannii in Thailand.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  54. MARIMUTHU K, Venkatachalam I, Khong WX, Koh TH, et al
    Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  55. TEERAWATTANAPONG N, Kengkla K, Dilokthornsakul P, Saokaew S, et al
    Prevention and Control of Multidrug-Resistant Gram-Negative Bacteria in Adult Intensive Care Units: A Systematic Review and Network Meta-analysis.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  56. PRUETPONGPUN N, Khawcharoenporn T, Damronglerd P, Suwantarat N, et al
    Inappropriate Empirical Treatment of Uncomplicated Cystitis in Thai Women: Lessons Learned.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  57. TARCHINI G, Liau KH, Solomkin JS
    Antimicrobial Stewardship in Surgery: Challenges and Opportunities.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  58. HONDA H, Ohmagari N, Tokuda Y, Mattar C, et al
    Antimicrobial Stewardship in Inpatient Settings in the Asia Pacific Region: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  59. MANSON AL, Abeel T, Galagan JE, Sundaramurthi JC, et al
    Mycobacterium tuberculosis Whole Genome Sequences From Southern India Suggest Novel Resistance Mechanisms and the Need for Region-Specific Diagnostics.
    Clin Infect Dis. 2017 May 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  60. SOCIAS ME, Nosova E, Kerr T, Hayashi K, et al
    Patterns of transmitted drug resistance and virological response to first-line antiretroviral treatment among HIV-positive people who use illicit drugs in a Canadian setting.
    Clin Infect Dis. 2017 May 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  61. GANDRA S, Trett A, Klein EY, Laxminarayan R, et al
    Is Antimicrobial Resistance a Bigger Problem in Tertiary Care Hospitals than in Small Community Hospitals in the United States?
    Clin Infect Dis. 2017 May 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. HEEMSKERK AD, Nguyen MTH, Dang HTM, Vinh Nguyen CV, et al
    Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen.
    Clin Infect Dis. 2017 May 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. TOTH DJA, Khader K, Slayton RB, Kallen AJ, et al
    The potential for interventions in a long-term acute care hospital to reduce transmission of carbapenem-resistant Enterobacteriaceae in affiliated healthcare facilities.
    Clin Infect Dis. 2017 May 3. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  64. RAVEN KE, Gouliouris T, Brodrick H, Coll F, et al
    Complex Routes of Nosocomial Vancomycin-Resistant Enterococcus faecium Transmission Revealed by Genome Sequencing.
    Clin Infect Dis. 2017;64:886-893.
    PubMed     Text format     Abstract available


  65. YANG S, Hemarajata P, Hindler J, Li F, et al
    Evolution and Transmission of Carbapenem-Resistant Klebsiella pneumoniae Expressing the blaOXA-232 Gene During an Institutional Outbreak Associated With Endoscopic Retrograde Cholangiopancreatography.
    Clin Infect Dis. 2017;64:894-901.
    PubMed     Text format     Abstract available


  66. TAMMA PD, Rodriguez-Bano J
    The Use of Noncarbapenem beta-Lactams for the Treatment of Extended-Spectrum beta-Lactamase Infections.
    Clin Infect Dis. 2017;64:972-980.
    PubMed     Text format     Abstract available


    March 2017
  67. HEO ST, Tatara AM, Jimenez-Ortigosa C, Jiang Y, et al
    Changes in in vitro susceptibility patterns of Aspergillus to triazoles and correlation with aspergillosis outcome in a tertiary care cancer center (1999-2015).
    Clin Infect Dis. 2017 Mar 31. doi: 10.1093.
    PubMed     Text format     Abstract available


  68. BILINSKI J, Grzesiowski P, Sorensen N, Madry K, et al
    Fecal Microbiota Transplantation in Patients with Blood Disorders Inhibits Gut Colonization with Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  69. WEBB BJ, Healy R, Majers J, Burr Z, et al
    Prediction of Bloodstream Infection due to Vancomycin-Resistant Enterococci in Patients Undergoing Leukemia Induction or Hematopoietic Stem Cell Transplantation.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  70. VAN HECKE O, Wang K, Lee JJ, Roberts NW, et al
    The implications of antibiotic resistance for patients' recovery from common infections in the community: a systematic review and meta-analysis.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  71. TSALIK EL, Petzold E, Kreiswirth BN, Bonomo RA, et al
    Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  72. ANDERSON DJ, Jenkins TC, Evans SR, Harris AD, et al
    The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  73. DOI Y, Bonomo RA, Hooper DC, Kaye KS, et al
    Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  74. DOERNBERG SB, Lodise TP, Thaden JT, Munita JM, et al
    Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  75. HUVANE J, Komarow L, Hill C, Tran TT, et al
    Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  76. MANCA C, Hill C, Hujer AM, Patel R, et al
    Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  77. CROSS HR, Harris A, Arias RM, Chambers HF, et al
    Transforming Concepts Into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  78. CHAMBERS HF, Cross HR, Evans SR, Kreiswirth BN, et al
    The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  79. MURRAY BE, Jezek A
    The Antibacterial Resistance Leadership Group: First Steps.
    Clin Infect Dis. 2017;64.
    PubMed     Text format    


  80. MUNITA JM, Aitken SL, Miller WR, Perez F, et al
    Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa.
    Clin Infect Dis. 2017 Mar 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  81. MARKS SM, Mase SR, Bamrah Morris S
    Systematic Review, Meta-Analysis, and Cost Effectiveness of Treatment of Latent Tuberculosis Infection to Reduce Progression to Multidrug-Resistant Tuberculosis.
    Clin Infect Dis. 2017 Mar 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  82. HEZODE C, Fourati S, Chevaliez S, Scoazec G, et al
    Sofosbuvir-Daclatasvir-Simeprevir plus Ribavirin in Direct-Acting Antiviral-Experienced Hepatitis C Patients.
    Clin Infect Dis. 2017 Mar 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  83. HOFSTRA LM, Sanchez Rivas E, Nijhuis M, Bank LE, et al
    High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  84. COLLINS IJ, Foster C, Tostevin A, Tookey P, et al
    Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  85. SEE I, Wesson P, Gualandi N, Dumyati G, et al
    Socioeconomic Factors Explain Racial Disparities in Invasive Community-Associated Methicillin-Resistant Staphylococcus aureus Disease Rates.
    Clin Infect Dis. 2017;64:597-604.
    PubMed     Text format     Abstract available


    February 2017
  86. THOMPSOM CN, Karkey A, Dongol S, Ariyal A, et al
    Treatment response in enteric fever in an era of increasing antimicrobial resistance: an individual patient data analysis of 2,092 participants enrolled into four randomised controlled trials in Nepal.
    Clin Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  87. ONG DS, Frencken JF, Klein Klouwenberg PM, Juffermans N, et al
    Short-course adjunctive gentamicin as empirical therapy in patients with severe sepsis and septic shock: a prospective observational cohort study.
    Clin Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  88. JOHNSTON JC, Campbell JR, Menzies D
    Effect of intermittency on treatment outcomes in pulmonary tuberculosis: an updated systematic review and meta-analysis.
    Clin Infect Dis. 2017 Feb 14. doi: 10.1093.
    PubMed     Text format    


  89. JACOBSON KR, Barnard M, Kleinman MB, Streicher EM, et al
    Implications of failure to routinely diagnose resistance to second-line drugs in patients with rifampicin-resistant tuberculosis on Xpert MTB/RIF: a multisite observational study.
    Clin Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  90. ROHDE AM, Gastmeier P
    Optimizing Proton Pump Inhibitor Use to Reduce Antimicrobial Resistance Rates?
    Clin Infect Dis. 2017 Feb 4. doi: 10.1093.
    PubMed     Text format    


  91. KOH WJ, Jeong BH, Kim SY, Jeon K, et al
    Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.
    Clin Infect Dis. 2017;64:309-316.
    PubMed     Text format     Abstract available


  92. READ TR, Fairley CK, Tabrizi SN, Bissessor M, et al
    Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance.
    Clin Infect Dis. 2017;64:250-256.
    PubMed     Text format     Abstract available


  93. PATEL R, Tsalik EL, Petzold E, Fowler VG Jr, et al
    MASTERMIND: Bringing Microbial Diagnostics to the Clinic.
    Clin Infect Dis. 2017;64:355-360.
    PubMed     Text format     Abstract available


  94. MOEHRING RW, Anderson DJ, Cochran RL, Hicks LA, et al
    Expert Consensus on Metrics to Assess the Impact of Patient-Level Antimicrobial Stewardship Interventions in Acute-Care Settings.
    Clin Infect Dis. 2017;64:377-383.
    PubMed     Text format     Abstract available


    January 2017
  95. CHUANG YC, Lin HY, Chen PY, Lin CY, et al
    Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
    Clin Infect Dis. 2017 Jan 25. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2016
  96. VINNARD C, King L, Munsiff S, Crossa A, et al
    The Long-Term Mortality of Tuberculosis Meningitis Patients in New York City: A Cohort Study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    October 2016
  97. LOCKHART SR, Etienne KA, Vallabhaneni S, Farooqi J, et al
    Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  98. LAVERGNE RA, Chouaki T, Hagen F, Toublanc B, et al
    Home environment as a source of life-threatening azole-resistant Aspergillus fumigatus in immunocompromised patients.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  99. GREBELY J, Dore GJ, Zeuzem S, Aspinall RJ, et al
    Efficacy and safety of sofosbuvir/velpatasvir in patients with chronic hepatitis C virus infection receiving opioid substitution therapy: Analysis of Phase 3 ASTRAL trials.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  100. WALKER E, Lyman A, Gupta K, Mahoney MV, et al
    Clinical management of an increasing threat: outpatient urinary tract infections due to multidrug-resistant uropathogens.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  101. KASSAYE SG, Grossman Z, Balamane M, Johnston-White B, et al
    Transmitted HIV Drug Resistance High and Longstanding in Metropolitan Washington, D.C.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  102. KNISELY JM, Liu B, Ranallo RT, Zou L, et al
    Vaccines for Hospital-Associated Infections: Promise and Challenge.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: